Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality offers new hope for chronic pain sufferers

NCT ID NCT06964360

Symptom relief Sponsor: Badalona Serveis Assistencials Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested a program called REDOCVR for 174 adults with chronic pain. The program combines group education, emotional support, and virtual reality experiences to help people reduce their pain medications. Researchers measured changes in medication use, mental well-being, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality-enhanced psychoeducational program
What this could lead to
If it works, this could offer a way to reduce reliance on painkillers and improve quality of life for people with chronic pain.
What could go wrong
This is a completed early-stage trial with no phase designation, so results may not be conclusive. The program is complex and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

174 people

The number who actually took part.

Started

May 2024

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (≥18 years) diagnosed with chronic non-cancer pain persisting for at least 3 months * Assigned to one of the participating primary care centers * Presence of central sensitization symptoms, emotional distress, kinesophobia, or inadequate response to prior treatments * Capacity to provide informed consent and complete questionnaires Exclusion Criteria: * Acute pain conditions (duration \<3 months) * Severe psychiatric or cognitive impairment * Uncontrolled vertigo, epilepsy, or major visual/auditory impairments * Conditions contraindicating use of VR equipment * Inability to attend scheduled sessions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Central sensitisation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Emotional Regulation opiate dependence Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Central sensitisation Chronic pain Opioid-related disorders Patient empowerment

Contacts and locations

Locations

  • CAP Montgat- Dr Jardi

    Montgat, Barcelona, Spain

  • Primary Care Center Apenins-Montigalà

    Badalona, Barcelona, 08917, Spain

  • Primary Care Center Morera-Pomar

    Badalona, Barcelona, Spain

  • Primary Care Progrès-Raval

    Badalona, Barcelona, 08912, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.